ONTELIAN Trademark

Trademark Overview


On Monday, February 25, 2019, a trademark application was filed for ONTELIAN with the United States Patent and Trademark Office. The USPTO has given the ONTELIAN trademark a serial number of 88314216. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 29, 2022. This trademark is owned by Pfizer Inc.. The ONTELIAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
ontelian

General Information


Serial Number88314216
Word MarkONTELIAN
Filing DateMonday, February 25, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 29, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, August 29, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 29, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 14, 2021SOU EXTENSION 5 GRANTED
Monday, December 6, 2021SOU EXTENSION 5 FILED
Tuesday, December 14, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 6, 2021TEAS EXTENSION RECEIVED
Saturday, June 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 3, 2021SOU EXTENSION 4 GRANTED
Thursday, June 3, 2021SOU EXTENSION 4 FILED
Thursday, June 3, 2021TEAS EXTENSION RECEIVED
Saturday, December 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 3, 2020SOU EXTENSION 3 GRANTED
Thursday, December 3, 2020SOU EXTENSION 3 FILED
Thursday, December 3, 2020TEAS EXTENSION RECEIVED
Saturday, May 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 28, 2020SOU EXTENSION 2 GRANTED
Thursday, May 28, 2020SOU EXTENSION 2 FILED
Thursday, May 28, 2020TEAS EXTENSION RECEIVED
Wednesday, December 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 9, 2019SOU EXTENSION 1 GRANTED
Monday, December 9, 2019SOU EXTENSION 1 FILED
Monday, December 9, 2019TEAS EXTENSION RECEIVED
Tuesday, July 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 28, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 8, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 15, 2019ASSIGNED TO EXAMINER
Friday, March 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 28, 2019NEW APPLICATION ENTERED IN TRAM